Serum to add diphtheria toxin plant

Serum Institute of India has commenced the construction of a new large scale cGMP production facility to manufacture CRM197, a non-toxic mutant of diphtheria toxin, for Phenex's Reagent Proteins division. The new facility, which will be able to produce 50kg/year of CRM197 using Pfenex's pseudomonas flourescens expression technology, is due to open in 2014.
GEN